ISRAEL TRUTH TIMES: CLAIM SHORTAGE, SO THE SHEEPLE WILL LINE UP! CFR CRIMINALS CAUGHT ON TAPE: SEE WHO THESE PEOPLE ARE, WHAT THEY HAVE TO GAIN FROM THIS; " UNHOLY ALLIANCE " OF VACCINE MANUFACTURERS, FOREMOST JESUIT UNIVERSITY, W.H.O., etc.....

Pandemic Influenza: Science, Economics, and Foreign Policy: Session One: The Science (Video)


Speakers:	Arnold Monto, Professor, Epidemiology, University of Michigan
	Peter Palese, Professor and Chair, Microbiology; and Professor of Medicine, Infectious Diseases, Mount Sinai School of Medicine
	Lone Simonsen, Research Professor and Research Director, Department of Global Health, George Washington University -PAY ATTENTION TO THE JESUIT CONNECTION , ONCE AGAIN!

Presider:		Jon Cohen, with the ubiquitous Jew for good measure and for cover.	Correspondent, Science Magazine

October 16, 2009

Conference Panel Session: Pandemic Influenza: Science, Economics, and Foreign Policy: The Science
Symposium: Pandemic Influenza: Science, Economics, and Foreign Policy

This session was part of a CFR symposium, Pandemic Influenza: Science, Economics, and Foreign Policy, which was cosponsored with Science Magazine.

Full-length video can be seen here:

http://www.cfr.org/publication/20439/pandemic_influenza.html

Thanks to Tamar.

AND PAY ATTENTION TO THE BUSINESS TIES OF THE SPEAKERS AS WELL!

These people are intimately connected with the vaccine manufacturing industry. And THESE are the people who want the public to take the toxic H1N1 vaccine; they are the ones who are devising media tricks to get people to line up for the poison. MONSTERS!

Notice how, while Peregrine is actively working on MONOCLONAL ANTIBODIES, a very good solution for severe viral infections, including influenza, they are pushing the POISON on the regular public.

The monoclonal antibodies will be reserved for the Jesuits, the CFR, and other such well- connected people, I would expect.

Notice also the intimate relationship between pharmaceutical company interests and professorships at various medical schools and universities. How on earth do you expect objective assessment of risks involved under these circumstances???

Peter Palese:

Professor and Chair of the Department of Microbiology, Mount Sinai School of Medicine, New York; Member, Vaccines and Related Biological Products Advisory Committee, FDA; Member, National Academy of Sciences; Co-Founder of Aviron, Inc. (later acquired by MedImmune); President-elect of the American Society for Virology

[NB: Medimmune is the company that manufactures the inhaled H1N1 vaccine used in the U.S. - DS]

Lone Simonsen:

During her 17-year career as an epidemiologist at Centers for Disease Control and Prevention (CDC), World Health Organization (WHO) and the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH, Dr. Simonsen developed novel tools and analysis methodology in a wide range of research projects. She has received multiple awards for her work from the Department of Health and Human Services, NIAID and CDC. Dr. Simonsen has also advised the Gates and Google Foundations and served as an expert advisor to CDC and WHO Advisory Committees on Immunization Practices and served as a technical advisor for several major pharmaceutical companies... Dr. Simonsen recently left the government and currently holds a visiting professor appointment at George Washington University School of Public Health.

Arnold Monto:

Arnold S. Monto, M.D. Professor of Epidemiology, School of Public Health of the University of Michigan President, American Epidemiological Society, 2004-2005 Robert W. Sidwell, Ph.D. Trustee Professor and Director of Institute for Antiviral Research, Utah State University ANTI-VIRAL - HIV Preston A. Marx, Ph.D. Chair and Core Scientist, Division of Microbiology and Immunology at Tulane National Primate Research Center Professor, Department of Tropical Medicine, School of Public Health and Tropical Medicine, Tulane University Health Sciences Center

Director of Institute at Peregrine Pharmaceuticals Inc

2008

http://www.peregrineinc.com/index.php?option=com_content&task=view&id=12&Itemid=26

Peregrine Pharmaceuticals, Inc. (NASDAQ-PPHM) is a biopharmaceutical company developing and manufacturing innovative monoclonal antibodies for the treatment of cancer and serious viral infections.

..... Peregrine is actively pursuing pre-clinical evaluation of bavituximab anti-viral against influenza and other viruses of public health and bioterrorism concern.